Applied BioCode, EraGen Reach MDx Pact

Applied BioCode's president said in a statement that the combination his firm's technology with EraGen's patented chemistry is expected to result in a "powerful testing platform for clinical laboratories."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.